Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Placeholder Photo
Barry Labinger
CEO, GILBOA THERAPEUTICS
Gilboa Therapeutics
Sam Lai, PhD
FOUNDER & INTERIM CEO, MUCOMMUNE, LLC
Mucommune, LLC
Durham, North Carolina, United States
Jenny Laird
VP, SEARCH & EVALUATION NEUROSCIENCE, ELI LILLY
Navigating the Neurodegenerative Diseases Labyrinth: Perspectives from Academia, Biotech, and Pharma
London, United Kingdom
Marc Lajoie, PhD
FOUNDER AND CHIEF EXECUTIVE OFFICER, OUTPACE BIO, INC.
Outpace Bio, Inc.
Seattle, Washington, United States
Darius Lakdawalla, PhD
PROFESSOR OF PHARMACEUTICAL ECONOMICS AND PUBLIC POLICY QUINTILES CHAIR IN PHARMACEUTICAL AND REGULATORY INNOVATION; DIRECTOR OF RESEARCH, SCHAEFFER CENTER, UNIVERSITY OF SOUTHERN CALIFORNIA
Determining Value: A Biotech Industry Discussion on Value Assessments and Alternative Proposals
Shaheen Lakhan, MD, PhD, FAAN
CHIEF MEDICAL OFFICER, CLICK THERAPEUTICS
DTx 2.0: The Promise of Digital Therapeutics
Johnny Lam
VP OF BUSINESS DEVELOPMENT, SCALEHEALTH
NIH Efforts for Supporting Small Business Entrepreneurs from Diverse Backgrounds
Dirk Landgraf, PhD
VP, DEMENTIA DISCOVERY FUND, SV HEALTH INVESTORS
Treating Neurodegeneration by Targeting the Mechanisms of Aging
Massachusetts, United States
Pepper Landson, ACA
CEO, PRAETEGO INC
Praetego Inc
Durham, North Carolina, United States
Edward Jr. Lang
CHIEF BUSINESS OFFICER, ANHEART THERAPEUTICS
The Evolving Landscape of Immunotherapy in Solid Cancers